Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-138549

Published: 2020

Journal Articles

Platelet CD34 Expression and a Congenital Collar Bone Malformation Associated with a Partial CBFB Deletion in a Case with a Bleeding Disorder

Maaike G.J.M. van Bergen, MSc, Joline L. Saes, MD, Annet Simons, PhD, Konnie M. Hebeda, PhD, Yvonne M.C. Henskens, PhD, Britta A.P. Laros-vanGorkom, MD PhD, Saskia E.M. Schols, MD PhD, Frank W.M.B. Preijers, PhD, Marjolijn C. Jongmans, MD PhD, Joop H. Jansen, PhD, Bert A. Van der Reijden, PhD

Blood (2019) 134 (Supplement_1): 1077.

https://doi.org/10.1182/blood-2019-128414

Published: 2019

Journal Articles

C-Terminal BRE Overexpression in 11q23-Rearranged and t(8;16) Acute Myeloid Leukemia Is Caused By Intragenic Transcription Initiation

Blood (2017) 130 (Supplement 1): 3810.

https://doi.org/10.1182/blood.V130.Suppl_1.3810.3810

Published: 2017

Journal Articles

Megakaryocyte Expansion and Platelet CD34 Expression Observed in GFI1B Q287* -Related Bleeding and Platelet Disorder Is Caused By Quenching of the Lysine Specific Demethylase LSD1/KDM1A

Rinske van Oorschot, MSc, Anna E. Marneth, MSc, Marten Hansen, BSc, Saskia M. Bergevoet, Alexander B. Meijer, PhD, Britta A.P. Laros-van-Gorkom, MD PhD, Joop H. Jansen, PhD, Marieke Von Lindern, PhD, Emile van den Akker, PhD, Bert A. van der Reijden, PhD

Blood (2016) 128 (22): 363.

https://doi.org/10.1182/blood.V128.22.363.363

Published: 2016

Journal Articles

A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia Patients

Blood (2015) 126 (23): 1357.

https://doi.org/10.1182/blood.V126.23.1357.1357

Published: 2015

Journal Articles

Gfi136N As a Novel Marker and Therapeutic Target of MDS and AML

Blood (2014) 124 (21): 3245.

https://doi.org/10.1182/blood.V124.21.3245.3245

Published: 2014

Journal Articles

A Dominant-Negative GFI1B Mutation in Gray Platelet Syndrome

Blood (2013) 122 (21): LBA-3.

https://doi.org/10.1182/blood.V122.21.LBA-3.LBA-3

Published: 2013

Journal Articles

A Single Nucleotide Polymorphism Of Growth Factor Independence 1 (GFI136N) is a Novel Prognostic Marker For The Progression Of Myelodysplastic Syndrome To Acute Myeloid Leukemia

Blood (2013) 122 (21): 2491.

https://doi.org/10.1182/blood.V122.21.2491.2491

Published: 2013

Journal Articles

The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9

Cyrus Khandanpour, MD, Joseph Krongold, BSc,, Judith Schütte, Frederique Bouwman, Lothar Vassen, PhD, Marie-Claude Gaudreau, M.Sc., Riyan Chen, PhD., Sara E. Meyer, PhD, H. Leighton Grimes, PhD, Bert A. Van der Reijden, PhD, Joop H. Jansen, PhD, Bob Lowenberg, MD, PhD, Justine K Peeters, Patel Chandrashekhar, Ulrich Duehrsen, MD, Berthold Goettgens, PhD., Tarik Moroy, Ph.D.

Blood (2011) 118 (21): 223.

https://doi.org/10.1182/blood.V118.21.223.223

Published: 2011

Journal Articles

Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation,

Willemijn Hobo, Kelly Broen, Walter J.F.M. van der Velden, MD, PhD, Annelies Greupink-Draaisma, Niken Adisty, Yannick Wouters, Michel G.D. Kester, Hanny Fredrix, Joop H. Jansen, PhD, Bert A. van der Reijden, PhD, J.H. Frederik Falkenburg, Theo de Witte, MD, PhD, Frank W.M.B. Preijers, PhD, Anton Schattenberg, MD, PhD, Ton Feuth, Nicole N.A. Blijlevens, MD, PhD, Nicolaas Schaap, MD, PhD, Harry Dolstra, PhD

Blood (2011) 118 (21): 4136.

https://doi.org/10.1182/blood.V118.21.4136.4136

Published: 2011

Journal Articles

MiR-132 and MiR-212 as Regulators of WT1 and GATA2 in Acute Myeloid Leukemia.

Maaike Luesink, MD, Jeannet Nigten, PhD, Ruth H.J.N. Knops, Theo J.M. de Witte, MD, PhD, Bert A. van der Reijden, PhD, Joop H. Jansen, PhD

Blood (2009) 114 (22): 1283.

https://doi.org/10.1182/blood.V114.22.1283.1283

Published: 2009

Journal Articles

BCL-2/IgH PCR Values at the End of Induction Treatment Are Not Predictive for Progression Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized Phase III Intergroup Trial.

Bert A. van der Reijden, PhD, Marinus H.J Van Oers, MD.PhD, Evelyn Tonissen, Martine Van Glabbeke, PhD, Livia Giurgia, Richard Klasa, MD.PhD, Robert E. Marcus, MD.PhD, Max Wolf, MD.PhD, Mars Van t Veer, MD.PhD, Andrej Vranovsky, MD, Harald Holte, MD, Eva Kimby, MD, Anton Hagenbeek, MD.PhD

Blood (2007) 110 (11): 791.

https://doi.org/10.1182/blood.V110.11.791.791

Published: 2007

Journal Articles

The Ubiquitin Ligase Triad1 Is Involved in Myelopoiesis and Interacts with the Transcriptional Repressors Gfi1 and Gfi1b.

Bert A. Van der Reijden, PhD, Jurgen A.F. Marteijn, Liesbeth Van Emst, Theo De Witte, PhD, MD, Joop H. Jansen, PhD

Blood (2004) 104 (11): 64.

https://doi.org/10.1182/blood.V104.11.64.64

Published: 2004

Journal Articles

Disruption of the NDE1 Gene Occurs in 90% of the Cases of inv(16) AML and Results in Chromosomal Instability and Myeloproliferative Disease in Mice.

Joop H. Jansen, PhD, Yuanyi Feng, PhD, Benjamin Lee, PhD, Marion Massop, Theo De Witte, PhD, MD, Ifor Williams, PhD, Gary Gilliland, PhD, MD, Chris Walsh, PhD, MD, Bert A. van der Reijden, PhD

Blood (2004) 104 (11): 61.

https://doi.org/10.1182/blood.V104.11.61.61

Published: 2004

NARROW

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Platelet CD34 Expression and a Congenital Collar Bone Malformation Associated with a Partial CBFB Deletion in a Case with a Bleeding Disorder

C-Terminal BRE Overexpression in 11q23-Rearranged and t(8;16) Acute Myeloid Leukemia Is Caused By Intragenic Transcription Initiation

Megakaryocyte Expansion and Platelet CD34 Expression Observed in GFI1B Q287* -Related Bleeding and Platelet Disorder Is Caused By Quenching of the Lysine Specific Demethylase LSD1/KDM1A

A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia Patients

Gfi136N As a Novel Marker and Therapeutic Target of MDS and AML

A Dominant-Negative GFI1B Mutation in Gray Platelet Syndrome

A Single Nucleotide Polymorphism Of Growth Factor Independence 1 (GFI136N) is a Novel Prognostic Marker For The Progression Of Myelodysplastic Syndrome To Acute Myeloid Leukemia

The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9

Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation,

MiR-132 and MiR-212 as Regulators of WT1 and GATA2 in Acute Myeloid Leukemia.

BCL-2/IgH PCR Values at the End of Induction Treatment Are Not Predictive for Progression Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized Phase III Intergroup Trial.

The Ubiquitin Ligase Triad1 Is Involved in Myelopoiesis and Interacts with the Transcriptional Repressors Gfi1 and Gfi1b.

Disruption of the NDE1 Gene Occurs in 90% of the Cases of inv(16) AML and Results in Chromosomal Instability and Myeloproliferative Disease in Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only